Skip to content
Sign In

Main Navigation

James Sharp Logo
  • Individuals
    Individuals

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service
  • Charities & Trustees
    Charities & Trustees

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • Companies
    Companies

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • News & Insights
    • News & Insights
    • Current Research Coverage List
  • About Us
    • About Us
    • Our People
  • Conectus Portal
  • Contact Us

Update - Page 38

25 June 2025

Daniel Thwaites Announce Share Buyback

Notification of Purchase of Own Shares Pursuant to the general authority given to the Company by its shareholders at its last annual general meeting…

25 June 2025

Sequoia – Final Results

Sequoia Economic Infrastructure Income Fund Limited (the “Company”) Final Results for the year ended 31 March 2025 Financial Highlights to 31 March 2025 31…

25 June 2025

Bankers Investment Trust Publish Half-Year Report

THE BANKERS INVESTMENT TRUST PLC (‘the Company’) Unaudited results for the half-year ended 30 April 2025 This announcement contains regulated information INVESTMENT OBJECTIVE  Over…

24 June 2025

Caledonia – Public Companies Spotlight

Caledonia Investments plc Public Companies spotlight event Caledonia Investments plc (“Caledonia”) will today host a spotlight on the Public Companies investment pool for investors…

24 June 2025

AstraZeneca Release Datroway Update

Datroway approved in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer Based on TROPION-Lung05 results and supported by data from TROPION-Lung01  …

23 June 2025

J.P.Morgan European Growth & Income – Final Results

LONDON STOCK EXCHANGE ANNOUNCEMENT JPMORGAN EUROPEAN GROWTH & INCOME PLC FINAL RESULTS FOR THE YEAR ENDED 31ST MARCH 2025 HIGHLIGHTS Performance All periods to 31st…

20 June 2025

GSK Release Arexvy Update

Japan’s Ministry of Health, Labour and Welfare accepts regulatory application to expand use of GSK’s RSV vaccine, Arexvy, in adults aged 18-49 at increased risk of…

20 June 2025

Carr’s Group – Results of Tender Offer

Carr’s Group plc (“Carr’s”, the “Group” or the “Company”) Results of Tender Offer and Total Voting Rights Following the close of the Tender Offer…

Posts navigation

  • «
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • …
  • 86
  • »

Home > Update > Page 38

James Sharp white Logo
Sign In
Linkedin Icon

The Exchange
5 Bank Street
Bury, Lancashire
BL9 0DN

Tel: 0161 764 4043

Fax: 0161 764 1628

Email: mail@jamessharp.co.uk

Linkedin Icon

James Sharp & Co is a trading name
of James Sharp & Co LLP (0C422665)

Members of the LLP are referred to as Partners

  • Downloads & Resources
  • Complaints
  • Financial Compensation Scheme
  • Conectus Portal

  • Cyber Essentials Certification
  • Website Terms & Conditions
  • Privacy Policy
  • Cookie policy
  • Consent Preferences

Email Newsletter Sign-up

Consent(Required)
What we do with you information. Find out more

© Copyright 2010-2026. All rights reserved. James Sharp & Co. Authorised & Regulated by the Financial Conduct Authority
Member of the London Stock Exchange - Member of the Aquis Stock Exchange - Member of PIMFA

Website by ICG